NCT04979715

The Effect of Early Rehabilitation After Breast Cancer Surgery on Physical and Psychosocial Functions

Completed NA Last updated 12 June 2023

What this trial tests

NA trial testing physitherapy follow-up in Breast Cancer Surgery in 63 participants. Completed in 19 January 2022.

Timeline

1 July 2020

Primary endpoint
19 December 2021

19 January 2022

Quick facts

Lead sponsor	Pamukkale University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	63
Start date	1 July 2020
Primary completion	19 December 2021
Estimated completion	19 January 2022
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

• physitherapy follow-up
• control

Conditions studied

• Breast Cancer Surgery — all drugs for Breast Cancer Surgery →

Sponsor

Pamukkale University

Who can join

Adults 30 to 65, female only, with Breast Cancer Surgery. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

At least 42 patients between the ages of 30-65, who were followed up in Pamukkale University General Surgery Breast Polyclinic and planned for breast surgery, will be included in the study. Those who met the criteria for inclusion in the study and those who voluntarily agreed to participate in the study, who were preoperatively evaluated, will be randomly divided into two groups using the closed envelope method by matching age, gender, type of surgery and breast cancer stage. The first of these groups is the study (n=21) and the second is the control group (n=21).

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

1. Cardiovascular training for fatigue in people with cancer.
   Wagner C, Ernst M, Cryns N, Oeser A, et al · · 2025 · cited 1× · PMID 39976199 · DOI 10.1002/14651858.cd015517
2. The effects of early rehabilitation on physical and psychosocial functions after breast cancer surgery.
   Kaş Özdemi̇r A, Telli Atalay O, Yılmaz S, Şenol H. · · 2025 · PMID 40987957 · DOI 10.1007/s00520-025-09926-4